FDA rejects AcelRx's request for meeting on pain drug device

The FDA rejects a request from AcelRx Pharmaceuticals for a meeting to discuss the need for another clinical trial of its Zalviso drug-device pain treatment.

AcelRx, Food & Drug Administration (FDA)

News Well, Drug-Device Combinations, Pain Management, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1E1WwyA